Apixaban renal dosing

Table 1 reviews direct oral anticoagulant dosing, including renal dose adjustments. Apixaban (Eliquis) renal dosing was included as 2.5 mg

Renal impairment. Dose adjustment may be required (see 2.5 DOAC dosing). dosing of apixaban. Refer to the University of Liverpool COVID

Apixaban (Eliquis). Contents [hide]. Dosing; Renal Dosing Adjustment; Conversions; Drug Interactions; Therapeutic

Moderate increase in apixaban concentrations in patients with normal renal function. Potentially significant increase in apixaban concentrations in patients with severe renal insufficiency: No dose adjustment recommended: USE WITH CAUTION in patients with normal renal function.

A letter to the editor clarifies the renal dosing of apixaban (Eliquis) for venous thromboembolism, based on the AMPLIFY trial and the manufacturer's recommendation. The authors recommend no dose adjustment for apixaban in patients with impaired renal function, but careful monitoring.

Apixaban Warfarin : Dabigatran contraindicated. Apixaban, rivaroxaban and edoxaban lower doses have been approved for patients with CrCl 15 - 30 mL/min. Apixaban is the least renally cleared and recommended by NICE for chronic kidney disease (CKD) patients. Moderate renal impairment (CrCl 30 - 50 mL/min) Apixaban Rivaroxaban 15 mg Edoxaban

by J Fanikos 2024 Cited by 5123 Additionally, apixaban-dosing adjustments are based on serum creatinine however, apixaban exposure increased with increasing renal impairment. A

View apixaban information, including dose, uses, side-effects, renal MHRA/CHM advice: New oral anticoagulants apixaban (Eliquis), dabigatran (Pradaxa) and

The results suggest that dose adjustment of apixaban is not required on the basis of renal function alone and that the drug was well tolerated in this study